BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8868295)

  • 1. Further investigations on the effects of neuropeptide Y on the secretion and growth of rat adrenal zona glomerulosa.
    Mazzocchi G; Malendowicz LK; Macchi C; Gottardo G; Nussdorfer GG
    Neuropeptides; 1996 Feb; 30(1):19-27. PubMed ID: 8868295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that endogenous somatostatin (SRIF) exerts an inhibitory control on the function and growth of rat adrenal zona glomerulosa. The possible involvement of zona medullaris as a source of endogenous SRIF.
    Rebuffat P; Belloni AS; Musajo FG; Rocco S; Markowska A; Mazzocchi G; Nussdorfer GG
    J Steroid Biochem Mol Biol; 1994 Mar; 48(4):353-60. PubMed ID: 7908223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that endogenous vasoactive intestinal peptide (VIP) plays a role in the maintenance of the growth and steroidogenic capacity of rat adrenal zona glomerulosa.
    Rebuffat P; Nowak KW; Tortorella C; Musajo FG; Gottardo G; Mazzocchi G; Nussdorfer GG
    J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):81-8. PubMed ID: 7947354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo studies of the effects of arginine-vasopressin on the secretion and growth of rat adrenal cortex.
    Mazzochi G; Malendowicz LK; Meneghelli V; Gottardo G; Nussdorfer GG
    Histol Histopathol; 1995 Apr; 10(2):359-70. PubMed ID: 7599433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro steroidogenic effects of neuropeptide Y (NPY1-36), Y1 and Y2 receptor agonists (Leu31-Pro34 NPY, NPY18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa.
    Bernet F; Maubert E; Bernard J; Montel V; Dupouy JP
    Regul Pept; 1994 Aug; 52(3):187-93. PubMed ID: 7800851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that endogenous substance-P (SP) is involved in the maintenance of the growth and steroidogenic capacity of rat adrenal zona glomerulosa.
    Mazzocchi G; Macchi C; Malendowicz LK; Nussdorfer GG
    Neuropeptides; 1995 Jul; 29(1):53-8. PubMed ID: 7566513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y (NPY)- and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerular zone could be mediated by catecholamines via beta 1 adrenergic receptors.
    Bernet F; Bernard J; Laborie C; Montel V; Maubert E; Dupouy JP
    Neurosci Lett; 1994 Jan; 166(1):109-12. PubMed ID: 8190350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a paracrine role of adrenomedullin in the physiological resetting of aldosterone secretion by rat adrenal zona glomerulosa.
    Albertin G; Malendowicz LK; Tortorella C; Mazzocchi G; Nussdorfer GG
    Peptides; 2000 Mar; 21(3):413-7. PubMed ID: 10793225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R; Andreis PG; Nussdorfer GG
    Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and receptor subtypes involved in the stimulatory action of endothelin-1 on rat adrenal zona glomerulosa.
    Rebuffat P; Mazzocchi G; Macchi C; Malendowicz LK; Gottardo G; Nussdorfer GG
    Int J Mol Med; 1999 Mar; 3(3):307-10. PubMed ID: 10028057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y modulates the sensitivity of the rat adrenal cortex to stimulation by ACTH.
    Hinson JP; Cameron LA; Kapas S
    J Endocrinol; 1995 May; 145(2):283-9. PubMed ID: 7616161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the signaling mechanisms involved in the ETB receptor-mediated secretagogue action of endothelin-1 on dispersed zona glomerulosa cells and capsule-zona glomerulosa preparations of the rat adrenal gland.
    Rebuffat P; Macchi C; Malendowicz LK; Nussdorfer GG
    Int J Mol Med; 2000 Jan; 5(1):43-7. PubMed ID: 10601572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of neuropeptide-Y and substance-P on the secretory activity of dispersed zona-glomerulosa cells of rat adrenal gland.
    Neri G; Andreis PG; Nussdorfer GG
    Neuropeptides; 1990 Nov; 17(3):121-5. PubMed ID: 1707502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sodium depletion on the response of rat adrenal zona glomerulosa cells to stimulation by neuropeptides: actions of vasoactive intestinal peptide, enkephalin, substance P, neuropeptide Y and corticotrophin-releasing hormone.
    Hinson JP; Kapas S
    J Endocrinol; 1995 Aug; 146(2):209-14. PubMed ID: 7561631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade.
    Malendowicz LK; Tortorella C; Nussdorfer GG
    J Steroid Biochem Mol Biol; 1999; 70(4-6):185-8. PubMed ID: 10622406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: Evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells.
    Andreis PG; Malendowicz LK; Trejter M; Neri G; Spinazzi R; Rossi GP; Nussdorfer GG
    FEBS Lett; 2003 Feb; 536(1-3):173-9. PubMed ID: 12586359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AT2 receptor-mediated stimulation of adrenal catecholamine release may potentiate the AT1 receptor-mediated aldosterone secretagogue action of angiotensin-II in rats.
    Mazzocchi G; Gottardo G; Macchi V; Malendowicz LK; Nussdorfer GG
    Endocr Res; 1998 Feb; 24(1):17-28. PubMed ID: 9553752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neuromedin-K on the rat hypothalamo-pituitary-adrenal axis.
    Malendowicz LK; Nussdorfer GG; Warchol JB; Markowska A; Macchi C; Nowak KW; Butowska W
    Neuropeptides; 1995 Dec; 29(6):337-41. PubMed ID: 8837961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prolonged cysteamine administration on the rat adrenal cortex: evidence that endogenous somatostatin is involved in the control of the growth and steroidogenic capacity of zona glomerulosa.
    Kasprzak A; Rebuffat P; Andreis PG; Mazzocchi G; Nussdorfer GG
    J Steroid Biochem Mol Biol; 1991 Apr; 38(4):469-73. PubMed ID: 1674425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that endogenous arginine-vasopressin (AVP) is involved in the maintenance of the growth and steroidogenic capacity of rat adrenal zona glomerulosa.
    Mazzocchi G; Markowska A; Malendowicz LK; Musajo F; Meneghelli V; Nussdorfer GG
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):251-6. PubMed ID: 8388707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.